USFDA Permits Ranbaxy to Produce And Sell Generic Atrovastitin in US Market

The United States Food And Drug Administration (USFDA) has accorded permission to Ranbaxy Laboratories to produce “Atrovastitin” – the generic version of Lipitor – a drug which lowers the levels of cholesterol.

Ranabaxy

The USFDA said: “Ranbaxy Laboratories Ltd has gained approval to make generic atorvastatin calcium tablets in 10 milligram, 20 mg, 40 mg, and 80 mg strengths. The drug will be manufactured by Ohm Laboratories in New Brunswick, NJ.”

In 2008, the USFDA banned 30 generic drugs produced by Ranbaxy at its plants in India because of alleged violations of manufacturing norms. It is not known whether the matter has been resolved.

This approval clears the ground for Ranbaxy to launch the product in the US market.

• About the Author

About Sprightly Spirit

“I dare do all that may become a man. Who dares more is none”. And all, may be. It may be the vigor. Or the spirit. Or the courage to avoid being “politically correct” or bent. And, ban all averse with immaculate overture of graciously fathomable words firm in views. Subtle. Justifying the undying conscience. Values. Knowledge. And, dares to stay true. True to own. True to the world. And, to the words. With a dream in eyes it exists. In you. In me. In all. The sprite that never shies away. The spirit that never dies!